// App-Quantinova.ai

: The Effect of Nintedanib on Clinical Outcome of 158 Patients with Idiopathic Pulmonary Fibrosis in Real World Settings

Researchers

Presenter

  • M. Dobashi

Principal Investigators

  • H. Tanaka

  • K. Taima

  • M. Itoga

  • Y. Ishioka

  • K. Baba

  • T. Shiratori

  • F. Okumura

  • C. Tabe

  • Y. Tanaka

  • Y. Hasegawa

  • H. Yasugahira

  • K. Okudera

  • S. Takanashi

  • S. Tasaka

Medical Centers

  • Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine., Hirosaki, Japan

  • Department of Respiratory Medicine, Hirosaki National Hospital, Hirosaki, Japan

  • Department of Respiratory Medicine, Iwate Prefectural Central Hospital, Morioka, Japan

  • Department of Respiratory Medicine, Hachinohe City Hospital, Hachinohe, Japan

  • Respiratory Medicine, Hirosaki Central Hospital, Hirosaki, Japan,

  • Health Administration Center, Hirosaki University, Hirosaki, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved